Peri-implant Tissues in BLX® Implants

NCT ID: NCT03720236

Last Updated: 2020-07-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-11-02

Study Completion Date

2020-06-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomized triple-blind clinical trial to evaluate the behavior of peri-implant tissues (bone and soft tissues) in BLX implants loaded early or delayed and with different surgical milling protocols. To this end, 40 BLX implants with a diameter of 3.75x10 will be placed in areas of mature bone scarred after extraction. They will be divided into 2 study groups, and these in turn into two subgroups. Group A: complete milling, Group B: partial milling. Each group will be assigned with code 1: early load and code 2: deferred load. Clinical and radiological parameters will be evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Implant Failed Dental Prosthesis Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Full preparation

Group A: the complete milling protocol indicated by the manufacturer for the 3.75x10 mm BLX implant will be performed.

Group Type EXPERIMENTAL

Implant bed preparation protocol

Intervention Type PROCEDURE

This is the first surgical phase, we prepare the implant bed by using different increasing size drills.

Partial preparation

Group B: the partial / under milling protocol for the 3.75x10 mm implant, indicated by the manufacturer, will be carried out.

Group Type EXPERIMENTAL

Implant bed preparation protocol

Intervention Type PROCEDURE

This is the first surgical phase, we prepare the implant bed by using different increasing size drills.

Deferred loading

Code 2: for implants with this random code, the prosthetic prosthesis SRA of 2.5 mm and its corresponding healing plug of 5.1 mm will be placed. Impressions will be taken at 6 weeks to place the provisional prosthesis at 8 weeks. At 6 months the final impressions will be taken for the definitive load.

Group Type EXPERIMENTAL

Implant loading

Intervention Type PROCEDURE

This is the second phase, based on prosthetic procedures, to design the crown over the dental implant

Immediate load

The code 1: to the implants with this random code, the prosthetic prosthesis SRA of 2.5 mm and its corresponding healing plug of 5.1 mm will be placed. The impression will be made in the same surgery and the placement of the provisional prosthesis before 7 days. At 6 months the final impressions will be taken for the definitive load.

Group Type EXPERIMENTAL

Implant loading

Intervention Type PROCEDURE

This is the second phase, based on prosthetic procedures, to design the crown over the dental implant

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Implant bed preparation protocol

This is the first surgical phase, we prepare the implant bed by using different increasing size drills.

Intervention Type PROCEDURE

Implant loading

This is the second phase, based on prosthetic procedures, to design the crown over the dental implant

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

IBP IL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients without systemic pathology
* Adult of age who agree to be part of the study and sign the informed consent.
* Patients smoking less than 5 cigarettes / day,
* Patients not being completely edentulous
* Unitary / multiple absences in the area posterior with or without free ends to distal, maxillary or mandibular that do not require regenerative techniques
* Area of mature bone healed at least 6 months post-extraction.
* The minimum torque for early loading will be 25 N. The placement of the implant will be mechanical up to 40 N maximum and manually finished with a surgical dynamometer.
* The placement of the abutment will be at a minimum of 25 N, in case the primary stability of the implant allows it, it will be placed at 35 N.
* The placement of the implant must always be 4 mm below the future gingival margi

Exclusion Criteria

* Immunosuppressed patients
* Aesthetic edentulous areas of 13-23 and 33-43
* Smokers of more than 5 cigarettes
* Implants with a lower torque whose will be submerged with a screw and a protocol will be followed in 2 phases, being discarded from the study.
* Index of bleeding greater than 30%
* Patients with less than 2 mm of keratinized gingiva
* Implants with ISQ index \<55
* When a margin of 1 mm safety cannot be assumed to the inferior dental nerve
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Manohay Dental SAU

UNKNOWN

Sponsor Role collaborator

University of Santiago de Compostela

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mario Pérez Sayáns

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mario Perez Sayans, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Santiago de Compostela

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mario Pérez Sayáns

Santiago de Compostela, A Coruña, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CT-2018-05

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.